Shares of Spectral Medical Inc. (TSE:EDT – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$1.38 and traded as high as C$1.42. Spectral Medical shares last traded at C$1.42, with a volume of 31,088 shares traded.
Spectral Medical Stock Up 2.9%
The firm has a market capitalization of C$416.65 million, a PE ratio of -10.92 and a beta of 0.65. The company has a fifty day simple moving average of C$1.38 and a two-hundred day simple moving average of C$1.35. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61.
Spectral Medical (TSE:EDT – Get Free Report) last issued its quarterly earnings data on Friday, May 8th. The company reported C($0.01) earnings per share for the quarter. The company had revenue of C$0.89 million during the quarter. Analysts forecast that Spectral Medical Inc. will post -0.05 EPS for the current fiscal year.
Spectral Medical Company Profile
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.
Featured Stories
- Five stocks we like better than Spectral Medical
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
